SANJIVANI PARANTERAL
|
SANJIVANI PARANTERAL Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Operational & Financial Ratios | ||
| Earnings Per Share (Rs) | 6.81 | 5.28 |
| CEPS(Rs) | 7.34 | 6.08 |
| DPS(Rs) | 0.50 | - |
| Book NAV/Share(Rs) | 30.83 | 22.14 |
| Tax Rate(%) | 21.81 | 18.58 |
| Margin Ratios | ||
| Core EBITDA Margin(%) | 14.14 | 14.70 |
| EBIT Margin(%) | 15.06 | 14.35 |
| Pre Tax Margin(%) | 14.24 | 13.89 |
| PAT Margin (%) | 11.13 | 11.31 |
| Cash Profit Margin (%) | 11.99 | 13.02 |
| Performance Ratios | ||
| ROA(%) | 13.31 | 14.20 |
| ROE(%) | 25.90 | 23.83 |
| ROCE(%) | 29.18 | 27.11 |
| Asset Turnover(x) | 1.20 | 1.26 |
| Sales/Fixed Asset(x) | 2.22 | 2.02 |
| Working Capital/Sales(x) | 30.45 | 3.67 |
| Efficiency Ratios | ||
| Fixed Capital/Sales(x) | 0.45 | 0.50 |
| Receivable days | 53.66 | 31.44 |
| Inventory Days | 50.82 | 65.15 |
| Payable days | 94.65 | 73.57 |
| Valuation Parameters | ||
| PER(x) | 35.17 | 28.44 |
| PCE(x) | 32.68 | 24.70 |
| Price/Book(x) | 7.77 | 6.78 |
| Yield(%) | 0.21 | - |
| EV/Net Sales(x) | 4.14 | 3.06 |
| EV/Core EBITDA(x) | 25.12 | 19.04 |
| EV/EBIT(x) | 26.54 | 21.31 |
| EV/CE(x) | 6.30 | 5.78 |
| M Cap / Sales | 4.06 | 3.22 |
| Growth Ratio | ||
| Net Sales Growth(%) | 28.83 | - |
| Core EBITDA Growth(%) | 32.06 | - |
| EBIT Growth(%) | 39.87 | - |
| PAT Growth(%) | 31.29 | - |
| EPS Growth(%) | 29.16 | - |
| Financial Stability Ratios | ||
| Total Debt/Equity(x) | 0.22 | 0.04 |
| Current Ratio(x) | 1.08 | 2.08 |
| Quick Ratio(x) | 0.74 | 1.37 |
| Interest Cover(x) | 18.47 | 30.86 |
| Total Debt/Mcap(x) | 0.03 | 0.01 |
Compare Financial Ratios of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹190.3 Cr | 3.1% | 6.3% | -29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | 3.1% |
6.3% |
-29.3% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses
